Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Equity Ratio (2019 - 2025)

AVITA Medical (RCEL) has disclosed Equity Ratio for 4 consecutive years, with 0.3 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 623.12% year-over-year to 0.3, compared with a TTM value of 0.3 through Dec 2025, down 623.12%, and an annual FY2025 reading of 0.3, down 623.12% over the prior year.
  • Equity Ratio was 0.3 for Q4 2025 at AVITA Medical, down from 0.1 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.92 in Q1 2022 and bottomed at 0.3 in Q4 2025.
  • Average Equity Ratio over 4 years is 0.41, with a median of 0.39 recorded in 2023.
  • The sharpest move saw Equity Ratio decreased 8.83% in 2023, then tumbled 623.12% in 2025.
  • Year by year, Equity Ratio stood at 0.86 in 2022, then crashed by 49.05% to 0.44 in 2023, then tumbled by 87.16% to 0.06 in 2024, then plummeted by 623.12% to 0.3 in 2025.
  • Business Quant data shows Equity Ratio for RCEL at 0.3 in Q4 2025, 0.1 in Q3 2025, and 0.22 in Q2 2025.